ERK1/2 promotes autophagic flux in chemoresistant gastric, breast, and ovarian cancer cells, but downregulates the same in basal or BRAF inhibitor resistant lung, breast, and PDAC cells10–12. This evidence concerns the gene MAPK3 and ovarian cancer.